These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7359313)

  • 21. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyclic AMP-affecting agents on contractile reactivity of isolated mesenteric and renal resistance arteries of the rat.
    Heesen BJ; De Mey JG
    Br J Pharmacol; 1990 Dec; 101(4):859-64. PubMed ID: 1707706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine sulfate stimulates the adenylate cyclase in mouse caudate nuclei.
    Tang LC; Cotzias GC
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1546-8. PubMed ID: 206908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous components of the striatum confer dopamine-sensitivity upon adenylate cyclase activity: the role of endogenous guanyl nucleotides.
    Chen TC; Cote TE; Kebabian JW
    Brain Res; 1980 Jan; 181(1):139-49. PubMed ID: 7350949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".
    Kebabian JW; Petzold GL; Greengard P
    Proc Natl Acad Sci U S A; 1972 Aug; 69(8):2145-9. PubMed ID: 4403305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ergotamine and dihydroergotamine on dopamine-stimulated adenylate cyclase in rat caudate nucleus.
    Govoni S; Iuliano E; Spano PF; Trabucchi M
    J Pharm Pharmacol; 1977 Jan; 29(1):45-7. PubMed ID: 13183
    [No Abstract]   [Full Text] [Related]  

  • 27. Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase.
    Tang LC; Cotzias GC
    Proc Natl Acad Sci U S A; 1977 Feb; 74(2):769-73. PubMed ID: 265541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users.
    Tong J; Ross BM; Schmunk GA; Peretti FJ; Kalasinsky KS; Furukawa Y; Ang LC; Aiken SS; Wickham DJ; Kish SJ
    Am J Psychiatry; 2003 May; 160(5):896-903. PubMed ID: 12727693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanine nucleotides regulate the effect of substance P on striatal adenylate cyclase of the rat.
    Moser A
    Biochem Biophys Res Commun; 1990 Feb; 167(1):211-5. PubMed ID: 1690002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
    Fleminger S
    Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal adenylate cyclase-inhibiting dopamine D2 receptors are not affected by the aging process.
    Missale C; Castelletti L; Pizzi M; Memo M; Carruba MO; Spano PF
    Neurosci Lett; 1987 Mar; 75(1):38-42. PubMed ID: 3033556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue.
    Riggs RM; Nichols DE; Foreman MM; Truex LL; Glock D; Kohli JD
    J Med Chem; 1987 Aug; 30(8):1454-8. PubMed ID: 2956423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 1991 Sep; 202(2):273-6. PubMed ID: 1839386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
    Ahn HS; Makman MH
    Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle.
    Drew GM; Hilditch A
    Br J Pharmacol; 1984 Dec; 83(4):871-81. PubMed ID: 6151412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by lithium of dopamine-sensitive adenylate-cyclase in the rat brain.
    Stefanini E; Longoni R; Fadda F; Spano PF; Gessa GL
    J Neurochem; 1978 Jan; 30(1):257-8. PubMed ID: 621512
    [No Abstract]   [Full Text] [Related]  

  • 40. Cultured mesenteric vascular smooth muscle cells express dopamine DA1-receptors.
    Balmforth AJ; Lyall F; Morton JI; Ball SG
    Eur J Pharmacol; 1988 Oct; 155(3):305-8. PubMed ID: 2853067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.